Perkins Investment Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$5.7M Sell
85,635
-6,878
-7% -$458K 0.07% 169
2016
Q4
$6.04M Sell
92,513
-4,546
-5% -$295K 0.08% 168
2016
Q3
$6.87M Buy
97,059
+3,372
+4% +$246K 0.09% 157
2016
Q2
$6.93M Buy
93,687
+20
+0% +$1.38K 0.1% 157
2016
Q1
$6.08M Sell
93,667
-35,571
-28% -$2.42M 0.09% 169
2015
Q4
$9.96M Sell
129,238
-28
-0% -$2.22K 0.15% 134
2015
Q3
$7.22M Sell
129,266
-16,514
-11% -$1.47M 0.1% 151
2015
Q2
$12.8M Sell
145,780
-30,258
-17% -$2.78M 0.15% 152
2015
Q1
$15.6M Sell
176,038
-59,830
-25% -$5.31M 0.16% 146
2014
Q4
$19.6M Sell
235,868
-2,570
-1% -$213K 0.18% 138
2014
Q3
$20.1M Sell
238,438
-25,900
-10% -$2.1M 0.18% 129
2014
Q2
$21.4M Sell
264,338
-36,827
-12% -$2.9M 0.17% 131
2014
Q1
$22.9M Sell
301,165
-11,935
-4% -$870K 0.18% 131
2013
Q4
$22.6M Buy
313,100
+16,757
+6% +$1.16M 0.16% 144
2013
Q3
$20.4M Sell
296,343
-33,201
-10% -$2.2M 0.14% 154
2013
Q2
$20.9M Buy
+329,544
New +$21.4M 0.14% 157

Other funds holding NVS

Perkins Investment Management's NVS Position: Q1 2017 in Review

Perkins Investment Management reduced its Novartis (NVS) stake by 7.4% in Q1 2017, selling an estimated $458K and leaving 85,635 shares worth $5.7M. The position accounts for 0.07% of the portfolio, ranked #169.

Perkins Investment Management first reported a position in NVS in Q2 2013 and has held it in 16 quarters since. The position peaked at $22.9M in Q1 2014. 910 funds tracked by Wall St. Rank hold NVS as of Q1 2017.

  • Perkins Investment Management held 85,635 shares of Novartis worth $5.7M as of Q1 2017.
  • Perkins Investment Management sold 6,878 Novartis shares in Q1 2017, an estimated $458K.
  • Novartis made up 0.07% of Perkins Investment Management's portfolio in Q1 2017, its #169 holding.
  • Perkins Investment Management first reported a position in Novartis in Q2 2013 and has held it in 16 quarters since.
  • Perkins Investment Management's Novartis position peaked at $22.9M in Q1 2014.
  • 910 funds tracked by Wall St. Rank held Novartis as of Q1 2017.

Based on Perkins Investment Management's 13F filing for Q1 2017, filed 15 May 2017.